Center for Vaccine Research and Pandemic Preparedness

Icahn School of Medicine at Mount Sinai

Websitehttps://icahn.mssm.edu/research/vaccine-research-pandemic-preparedness

52869 Citations
113 h-index
566 Article
44 Review article
29 Comment/debate
16 Letter
More

AddaVax, AddaS03, and Alum Effectively Enhance Cross-Reactive and Cross-Neutralizing Antibody Responses Against SARS-CoV-2 Induced by the Inactivated NDV-HXP-S Vaccine in Mice
Martínez-Guevara, J. L., Lai, T. Y., Mishra, M., Slamanig, S., González-Domínguez, I., Abdeljawad, A., Hoang, M. T., Singh, G., Kowdle, S., Lee, B., Krammer, F., Palese, P. & Sun, W., Feb 2026, In: Vaccines. 14, 2, 138.
Research output: Contribution to journal › Article › peer-review

Open Access
An H5N1 clade 2.3.4.4b virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteins
Puente-Massaguer, E., Galdino Andrade, T., Scherm, M. J., Vasilev, K., Abozeid, H., Rodriguez, A. J., Yueh, J., Bhavsar, D., Campbell, J. D., Yu, D., Webby, R. J., Kawaoka, Y., Neumann, G., Han, J., Ward, A. B. & Krammer, F., Dec 2026, In: Nature Communications. 17, 1, 1749.
Research output: Contribution to journal › Article › peer-review

Open Access
Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination
Abbad, A., Lerman, B., Ehrenhaus, J., Monahan, B., Singh, G., Wilson, A., Slamanig, S., Aracena, A., Lyttle, N., Nardulli, J. R., Farrugia, K., Khalil, Z., Gonzalez-Reiche, A. S., Sordillo, M. E., Sun, W., van Bakel, H., Simon, V. & Krammer, F., Jan 2026, In: mBio. 17, 1, p. 1-7 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
7 Scopus citations
Association of influenza viral genetic information with severity markers in patients hospitalised with influenza: Multicentre retrospective cohort study
Myint, A. P., Shirreff, G., Baillie, V., Bal, A., Boutros, C. F., Burtseva, E., Coulibaly, D., Danilenko, D., Dbaibo, G., Destras, G., Dia, N., Draganescu, A. C., Giamberardino, H. I. G., Komissarov, A. B., Koul, P. A., Laguna-Torres, V. A., Leblanc, J. J., Mira-Iglesias, A., Mironenko, A. & Orrico-Sánchez, A. & 21 others, Otieno, N. A., Sandulescu, O., Simon, V., Sominina, A., Sordillo, E., Tanriover, M. D., Teteriuk, N., Unal, S., Van Bakel, H., Andrew, M. K., Bresee, J., Lina, B., López-Labrador, F. X., Ortiz, J. R., Raboni, S. M., Zhang, W., Chaves, S. S., Cacciapaglia, G., Josset, L., Chauvel, C. & Nunes, M. C., 8 Jan 2026, In: BMJ Open. 16, 1, e111643.
Research output: Contribution to journal › Article › peer-review

Open Access
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors (Communications Medicine, (2026), 6, 1, (1), 10.1038/s43856-025-01230-w)
IMPACC Network, Dec 2026, In: Communications Medicine. 6, 1, 125.
Research output: Contribution to journal › Comment/debate

Open Access
B cell imprinting in children impairs antibodies to the haemagglutinin stalk
Sun, J., Jo, G., Troxell, C. A., Fu, Y., Hoezl, R., Lv, H., Abozeid, H. H., Teo, Q. W., Pholcharee, T., McGrath, J. J. C., Changrob, S., Nelson, S. A., Yasuhara, A., Huang, M., Zheng, N. Y., Chervin, J. C., Li, L., Fernández-Quintero, M. L., Loeffler, J. R. & Rodriguez, A. J. & 17 others, Huang, J., Swanson, O. M., Balmaseda, A., Kuan, G., Campredon, L., Kaitlynn Allen, E., Neumann, G., Wu, N. C., Kawaoka, Y., Krammer, F., Mejias, A., Ramilo, O., Thomas, P. G., Gordon, A., Ward, A. B., Han, J. & Wilson, P. C., 14 May 2026, In: Nature. 653, 8114, p. 528-537 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
B lymphocyte protein factories produced by hematopoietic stem cell gene editing
Hartweger, H., Ruprecht, C., Yao, K. H., Laffont, P., Lima Dos Reis, G., Zhou, P., Hägglöf, T., Binet, L., Loewe, M., Hong, J. P., Xiao, T., Sefik, E., Hernandez, B., Gazumyan, A., Jankovic, M., Seaman, M. S., Costa, G., Nelson, S. A., Clark, J. & Kanatani, S. & 9 others, Wilson, P. C., Krammer, F., Levashina, E. A., Julien, J. P., Wardemann, H., Sinnis, P., Stamatatos, L., Flavell, R. A. & Nussenzweig, M. C., 16 Apr 2026, In: Science. 392, 6795, eadz8994.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Clinical Characteristics and Severity of Rhinovirus/Enterovirus–Associated Hospitalizations: A Multicountry Analysis From the Global Influenza Hospital Surveillance Network, 2017–2024
Revilla, A. M., Raboni, S. M., Giamberardino, H. I. G., Andrew, M. K., Badar, N., Baillie, V., Baumeister, E., Burtseva, E., Dbaibo, G., Dia, N., Drăgănescu, A. C., Koul, P. A., Simon, V., Sordillo, E., van Bakel, H., Sominina, A., Zhang, T., López-Labrador, F. X., Mira-Iglesias, A. & Orrico-Sánchez, A. & 5 others, Huang, Q. S., Bresee, J., Ortiz, J. R., Nunes, M. C. & Chaves, S. S., Apr 2026, In: Open Forum Infectious Diseases. 13, 4
Research output: Contribution to journal › Article › peer-review

Open Access
Corrigendum to “Sustained superior humoral immune responses of mRNA vaccines compared to Sputnik V viral vector COVID-19 vaccines in naïve and convalescent populations” [Vaccine 70 (2026) 128018]
Abbad, A., Lerman, B., Ehrenhaus, J., Ojeda, D. S., Gleason, C., Singh, G., Khalil, Z., Gonzalez-Reiche, A. S., Srivastava, K., Fernandez-Sesma, A., Gamarnik, A., Simon, V. & Krammer, F., 2 Apr 2026, In: Vaccine. 77, 128333.
Research output: Contribution to journal › Comment/debate

Open Access
Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infection
Clark, J. J., Hatzl, S., Vasilev, K., Andreata-Santos, R., Yong, J. S., Mittler, E., Kasikci, E., Chandran, K., Simon, V., Krause, R. & Krammer, F., Feb 2026, In: eBioMedicine. 124, 106091.
Research output: Contribution to journal › Article › peer-review

Open Access
Cross-reactive human antibody responses to H9N2 influenza virus, New York, United States, 2025
Singh, G., Bhavsar, D., Ferreri, L. M., Nardulli, J. R., Gleason, C., Lyttle, N., Chen, Y., Lowen, A. C., Simon, V. & Krammer, F., 21 May 2026, In: Eurosurveillance. 31, 20, 2600375.
Research output: Contribution to journal › Article › peer-review

Open Access
Empirical Antifungal Treatment of Critically Ⅲ Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Propensity Score Weighted Observational Study
Hatzl, S., Kriegl, L., Geiger, C., Wilhelmer, C., Reisinger, A. C., Keldorfer, M., Auinger, J., Schilcher, G., Krammer, F., Eller, P. & Krause, R., 15 Mar 2026, In: Clinical Infectious Diseases. 82, 3, p. e485-e493
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations

The Next Pandemic May Already Be Brewing
Krammer, F.
25/05/26
1 item of Media coverage
Press/Media
New Findings from Icahn School of Medicine at Mount Sinai Describe Advances in Vaccines (A TRAC-478-adjuvanted recombinant N1 neuraminidase influenza virus vaccine induces balanced and broadly protective immune responses)
Krammer, F. & Puente-Massaguer, E.
20/05/26
1 item of Media coverage
Press/Media
Your nose is a battlefield
Krammer, F.
30/04/26
1 item of Media coverage
Press/Media
Recent Findings from Icahn School of Medicine at Mount Sinai Provide New Insights into Influenza B Virus (Influenza B mosaic HA mRNA-LNP vaccines are cross-reactive and protective in mice)
Krammer, F., Palese, P. & Puente-Massaguer, E.
30/04/26
1 item of Media coverage
Press/Media
U.S. Patents Awarded to Inventors in New York (April 28)
Nelson,, J., Rapoport, B., Krammer, F., Palese, P., Lee, Y., Garcia-Sastre, A., Katz, M., Stein, D., Sun, W. & Murray, M.
28/04/26
1 item of Media coverage
Press/Media
Recombinant Vaccine Against COVID-19 Based on a Paramyxovirus Viral Vector
Krammer, F., Palese, P., Garcia-Sastre, A. & Sun, W.
28/04/26
1 item of Media coverage
Press/Media
Researchers at Icahn School of Medicine at Mount Sinai Release New Data on Vaccines (Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies)
Krammer, F. & Simon, V.
24/04/26
1 item of Media coverage
Press/Media
New Findings from Icahn School of Medicine at Mount Sinai in the Area of Vaccines Reported (Stabilized mosaic hemagglutinin immunogens as novel universal influenza virus vaccines)
Krammer, F., Palese, P. & Puente-Massaguer, E.
7/04/26
1 item of Media coverage
Press/Media
New Cicada COVID-19 Variant: Symptoms and Risks for Children
Krammer, F.
6/04/26
1 item of Media coverage
Press/Media
New COVID-19 Findings from Icahn School of Medicine at Mount Sinai Discussed (The buried S2 apex of SARS-CoV-2 spike elicits an immunodominant germline-restricted public antibody response)
Krammer, F., Mulder, L. & Simon, V.
30/03/26
1 item of Media coverage
Press/Media
Researchers from University of California San Diego (UCSD) Detail Findings in COVID-19 (Impact of Covid-19 Monoclonal Antibody Therapy On Subsequent Vaccine-elicited Sars-cov-2 Immune Responses)
Coelho, C.
26/03/26
1 item of Media coverage
Press/Media
Influenza Strain Partially Dodges Existing Immunity and Current Vaccine, BIDMC-Led Study Finds
van Bakel, H., Sordillo, E. & Simon, V.
11/03/26
1 item of Media coverage
Press/Media

Center for Vaccine Research and Pandemic Preparedness

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Camila Coelho

Florian Krammer

Viviana Simon

AddaVax, AddaS03, and Alum Effectively Enhance Cross-Reactive and Cross-Neutralizing Antibody Responses Against SARS-CoV-2 Induced by the Inactivated NDV-HXP-S Vaccine in Mice

An H5N1 clade 2.3.4.4b virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteins

Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination

Association of influenza viral genetic information with severity markers in patients hospitalised with influenza: Multicentre retrospective cohort study

Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors (Communications Medicine, (2026), 6, 1, (1), 10.1038/s43856-025-01230-w)

B cell imprinting in children impairs antibodies to the haemagglutinin stalk

B lymphocyte protein factories produced by hematopoietic stem cell gene editing

Clinical Characteristics and Severity of Rhinovirus/Enterovirus–Associated Hospitalizations: A Multicountry Analysis From the Global Influenza Hospital Surveillance Network, 2017–2024

Corrigendum to “Sustained superior humoral immune responses of mRNA vaccines compared to Sputnik V viral vector COVID-19 vaccines in naïve and convalescent populations” [Vaccine 70 (2026) 128018]

Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infection

Cross-reactive human antibody responses to H9N2 influenza virus, New York, United States, 2025

Empirical Antifungal Treatment of Critically Ⅲ Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Propensity Score Weighted Observational Study

The Next Pandemic May Already Be Brewing

New Findings from Icahn School of Medicine at Mount Sinai Describe Advances in Vaccines (A TRAC-478-adjuvanted recombinant N1 neuraminidase influenza virus vaccine induces balanced and broadly protective immune responses)

Your nose is a battlefield

Recent Findings from Icahn School of Medicine at Mount Sinai Provide New Insights into Influenza B Virus (Influenza B mosaic HA mRNA-LNP vaccines are cross-reactive and protective in mice)

U.S. Patents Awarded to Inventors in New York (April 28)

Recombinant Vaccine Against COVID-19 Based on a Paramyxovirus Viral Vector

Researchers at Icahn School of Medicine at Mount Sinai Release New Data on Vaccines (Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies)

New Findings from Icahn School of Medicine at Mount Sinai in the Area of Vaccines Reported (Stabilized mosaic hemagglutinin immunogens as novel universal influenza virus vaccines)

New Cicada COVID-19 Variant: Symptoms and Risks for Children

New COVID-19 Findings from Icahn School of Medicine at Mount Sinai Discussed (The buried S2 apex of SARS-CoV-2 spike elicits an immunodominant germline-restricted public antibody response)

Researchers from University of California San Diego (UCSD) Detail Findings in COVID-19 (Impact of Covid-19 Monoclonal Antibody Therapy On Subsequent Vaccine-elicited Sars-cov-2 Immune Responses)

Influenza Strain Partially Dodges Existing Immunity and Current Vaccine, BIDMC-Led Study Finds

Center for Vaccine Research and Pandemic Preparedness

Fingerprint

Collaborations and top research areas from the last five years

Profiles

Research output

Press/Media